nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—Prednisone—ankylosing spondylitis	0.0808	0.124	CbGbCtD
Clomipramine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0698	0.107	CbGbCtD
Clomipramine—CYP2C19—Prednisone—ankylosing spondylitis	0.0524	0.0806	CbGbCtD
Clomipramine—ABCB1—Betamethasone—ankylosing spondylitis	0.0454	0.0698	CbGbCtD
Clomipramine—ABCB1—Prednisolone—ankylosing spondylitis	0.0448	0.0689	CbGbCtD
Clomipramine—ABCB1—Prednisone—ankylosing spondylitis	0.0423	0.0651	CbGbCtD
Clomipramine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0418	0.0643	CbGbCtD
Clomipramine—ALB—Methotrexate—ankylosing spondylitis	0.0405	0.0624	CbGbCtD
Clomipramine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0327	0.0503	CbGbCtD
Clomipramine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0317	0.0488	CbGbCtD
Clomipramine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0272	0.0418	CbGbCtD
Clomipramine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0268	0.0413	CbGbCtD
Clomipramine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0264	0.0406	CbGbCtD
Clomipramine—CYP3A4—Prednisone—ankylosing spondylitis	0.0253	0.039	CbGbCtD
Clomipramine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0249	0.0383	CbGbCtD
Clomipramine—ABCB1—Methotrexate—ankylosing spondylitis	0.0212	0.0326	CbGbCtD
Clomipramine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0158	0.0243	CbGbCtD
Clomipramine—Syncope—Dexamethasone—ankylosing spondylitis	0.000275	0.000784	CcSEcCtD
Clomipramine—Arrhythmia—Prednisone—ankylosing spondylitis	0.000274	0.000782	CcSEcCtD
Clomipramine—Sweating—Methotrexate—ankylosing spondylitis	0.000273	0.000781	CcSEcCtD
Clomipramine—Haematuria—Methotrexate—ankylosing spondylitis	0.000272	0.000777	CcSEcCtD
Clomipramine—Shock—Triamcinolone—ankylosing spondylitis	0.000271	0.000774	CcSEcCtD
Clomipramine—Insomnia—Prednisolone—ankylosing spondylitis	0.000271	0.000774	CcSEcCtD
Clomipramine—Alopecia—Prednisone—ankylosing spondylitis	0.000271	0.000773	CcSEcCtD
Clomipramine—Shock—Methylprednisolone—ankylosing spondylitis	0.00027	0.000772	CcSEcCtD
Clomipramine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00027	0.00077	CcSEcCtD
Clomipramine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00027	0.00077	CcSEcCtD
Clomipramine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000269	0.000769	CcSEcCtD
Clomipramine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000269	0.000769	CcSEcCtD
Clomipramine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000269	0.000768	CcSEcCtD
Clomipramine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000269	0.000768	CcSEcCtD
Clomipramine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000269	0.000768	CcSEcCtD
Clomipramine—Mental disorder—Prednisone—ankylosing spondylitis	0.000268	0.000766	CcSEcCtD
Clomipramine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000268	0.000766	CcSEcCtD
Clomipramine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000267	0.000762	CcSEcCtD
Clomipramine—Malnutrition—Prednisone—ankylosing spondylitis	0.000267	0.000762	CcSEcCtD
Clomipramine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000266	0.00076	CcSEcCtD
Clomipramine—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000266	0.00076	CcSEcCtD
Clomipramine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000266	0.000759	CcSEcCtD
Clomipramine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000265	0.000758	CcSEcCtD
Clomipramine—Convulsion—Betamethasone—ankylosing spondylitis	0.000265	0.000758	CcSEcCtD
Clomipramine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000264	0.000755	CcSEcCtD
Clomipramine—Hypertension—Betamethasone—ankylosing spondylitis	0.000264	0.000755	CcSEcCtD
Clomipramine—Myalgia—Betamethasone—ankylosing spondylitis	0.000261	0.000745	CcSEcCtD
Clomipramine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000261	0.000745	CcSEcCtD
Clomipramine—Anxiety—Betamethasone—ankylosing spondylitis	0.00026	0.000742	CcSEcCtD
Clomipramine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00026	0.000742	CcSEcCtD
Clomipramine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000258	0.000736	CcSEcCtD
Clomipramine—Discomfort—Betamethasone—ankylosing spondylitis	0.000258	0.000736	CcSEcCtD
Clomipramine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000257	0.000733	CcSEcCtD
Clomipramine—Pain—Prednisolone—ankylosing spondylitis	0.000256	0.000731	CcSEcCtD
Clomipramine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000256	0.000731	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000254	0.000726	CcSEcCtD
Clomipramine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000253	0.000722	CcSEcCtD
Clomipramine—Vision blurred—Prednisone—ankylosing spondylitis	0.000251	0.000718	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000251	0.000717	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000251	0.000717	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00025	0.000715	CcSEcCtD
Clomipramine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00025	0.000714	CcSEcCtD
Clomipramine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00025	0.000714	CcSEcCtD
Clomipramine—Oedema—Dexamethasone—ankylosing spondylitis	0.00025	0.000714	CcSEcCtD
Clomipramine—Oedema—Betamethasone—ankylosing spondylitis	0.00025	0.000714	CcSEcCtD
Clomipramine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000249	0.000711	CcSEcCtD
Clomipramine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000249	0.00071	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000247	0.000707	CcSEcCtD
Clomipramine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000247	0.000706	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000247	0.000705	CcSEcCtD
Clomipramine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000247	0.000705	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000247	0.000705	CcSEcCtD
Clomipramine—Anaemia—Prednisone—ankylosing spondylitis	0.000247	0.000704	CcSEcCtD
Clomipramine—Shock—Dexamethasone—ankylosing spondylitis	0.000246	0.000702	CcSEcCtD
Clomipramine—Shock—Betamethasone—ankylosing spondylitis	0.000246	0.000702	CcSEcCtD
Clomipramine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000246	0.000701	CcSEcCtD
Clomipramine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000245	0.0007	CcSEcCtD
Clomipramine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000245	0.0007	CcSEcCtD
Clomipramine—Agitation—Prednisone—ankylosing spondylitis	0.000245	0.0007	CcSEcCtD
Clomipramine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000245	0.000699	CcSEcCtD
Clomipramine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000245	0.000699	CcSEcCtD
Clomipramine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000244	0.000697	CcSEcCtD
Clomipramine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000244	0.000697	CcSEcCtD
Clomipramine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000242	0.000692	CcSEcCtD
Clomipramine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000242	0.000691	CcSEcCtD
Clomipramine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000242	0.00069	CcSEcCtD
Clomipramine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000242	0.00069	CcSEcCtD
Clomipramine—Malaise—Prednisone—ankylosing spondylitis	0.000241	0.000687	CcSEcCtD
Clomipramine—Vertigo—Prednisone—ankylosing spondylitis	0.00024	0.000684	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—ankylosing spondylitis	0.000239	0.000683	CcSEcCtD
Clomipramine—Syncope—Prednisone—ankylosing spondylitis	0.000239	0.000683	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—ankylosing spondylitis	0.000239	0.000682	CcSEcCtD
Clomipramine—Anorexia—Betamethasone—ankylosing spondylitis	0.000238	0.00068	CcSEcCtD
Clomipramine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000238	0.00068	CcSEcCtD
Clomipramine—Urticaria—Prednisolone—ankylosing spondylitis	0.000238	0.00068	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000238	0.000679	CcSEcCtD
Clomipramine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000237	0.000678	CcSEcCtD
Clomipramine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000237	0.000677	CcSEcCtD
Clomipramine—Pain—Triamcinolone—ankylosing spondylitis	0.000236	0.000673	CcSEcCtD
Clomipramine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000234	0.000669	CcSEcCtD
Clomipramine—Hypotension—Betamethasone—ankylosing spondylitis	0.000234	0.000667	CcSEcCtD
Clomipramine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000234	0.000667	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000232	0.000663	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000231	0.00066	CcSEcCtD
Clomipramine—Convulsion—Prednisone—ankylosing spondylitis	0.000231	0.00066	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000231	0.000659	CcSEcCtD
Clomipramine—Hypertension—Prednisone—ankylosing spondylitis	0.00023	0.000658	CcSEcCtD
Clomipramine—Chills—Methotrexate—ankylosing spondylitis	0.00023	0.000656	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000228	0.00065	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000228	0.00065	CcSEcCtD
Clomipramine—Myalgia—Prednisone—ankylosing spondylitis	0.000227	0.000648	CcSEcCtD
Clomipramine—Arthralgia—Prednisone—ankylosing spondylitis	0.000227	0.000648	CcSEcCtD
Clomipramine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000227	0.000648	CcSEcCtD
Clomipramine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000226	0.000647	CcSEcCtD
Clomipramine—Anxiety—Prednisone—ankylosing spondylitis	0.000226	0.000646	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—ankylosing spondylitis	0.000226	0.000646	CcSEcCtD
Clomipramine—Insomnia—Betamethasone—ankylosing spondylitis	0.000226	0.000646	CcSEcCtD
Clomipramine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000226	0.000646	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000225	0.000644	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000225	0.000642	CcSEcCtD
Clomipramine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000224	0.000641	CcSEcCtD
Clomipramine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000224	0.000641	CcSEcCtD
Clomipramine—Discomfort—Prednisone—ankylosing spondylitis	0.000224	0.000641	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000224	0.000641	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000223	0.000636	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000221	0.00063	CcSEcCtD
Clomipramine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00022	0.000628	CcSEcCtD
Clomipramine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00022	0.000628	CcSEcCtD
Clomipramine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000219	0.000625	CcSEcCtD
Clomipramine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000218	0.000623	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000218	0.000623	CcSEcCtD
Clomipramine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000218	0.000622	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000218	0.000622	CcSEcCtD
Clomipramine—Oedema—Prednisone—ankylosing spondylitis	0.000218	0.000622	CcSEcCtD
Clomipramine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000217	0.00062	CcSEcCtD
Clomipramine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000217	0.00062	CcSEcCtD
Clomipramine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000217	0.00062	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000216	0.000616	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000216	0.000616	CcSEcCtD
Clomipramine—Back pain—Methotrexate—ankylosing spondylitis	0.000216	0.000616	CcSEcCtD
Clomipramine—Fatigue—Betamethasone—ankylosing spondylitis	0.000215	0.000615	CcSEcCtD
Clomipramine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000215	0.000615	CcSEcCtD
Clomipramine—Shock—Prednisone—ankylosing spondylitis	0.000214	0.000612	CcSEcCtD
Clomipramine—Pain—Dexamethasone—ankylosing spondylitis	0.000214	0.00061	CcSEcCtD
Clomipramine—Pain—Betamethasone—ankylosing spondylitis	0.000214	0.00061	CcSEcCtD
Clomipramine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000213	0.00061	CcSEcCtD
Clomipramine—Tachycardia—Prednisone—ankylosing spondylitis	0.000212	0.000607	CcSEcCtD
Clomipramine—Skin disorder—Prednisone—ankylosing spondylitis	0.000211	0.000604	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00021	0.000601	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00021	0.0006	CcSEcCtD
Clomipramine—Anorexia—Prednisone—ankylosing spondylitis	0.000207	0.000592	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000207	0.000591	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—ankylosing spondylitis	0.000206	0.000588	CcSEcCtD
Clomipramine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000206	0.000588	CcSEcCtD
Clomipramine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000206	0.000588	CcSEcCtD
Clomipramine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000204	0.000584	CcSEcCtD
Clomipramine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000204	0.000584	CcSEcCtD
Clomipramine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000203	0.00058	CcSEcCtD
Clomipramine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000203	0.000578	CcSEcCtD
Clomipramine—Malaise—Methotrexate—ankylosing spondylitis	0.000201	0.000574	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—ankylosing spondylitis	0.0002	0.000572	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—ankylosing spondylitis	0.0002	0.00057	CcSEcCtD
Clomipramine—Urticaria—Betamethasone—ankylosing spondylitis	0.000199	0.000567	CcSEcCtD
Clomipramine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000199	0.000567	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000198	0.000566	CcSEcCtD
Clomipramine—Dizziness—Prednisolone—ankylosing spondylitis	0.000198	0.000566	CcSEcCtD
Clomipramine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000198	0.000564	CcSEcCtD
Clomipramine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000198	0.000564	CcSEcCtD
Clomipramine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000198	0.000564	CcSEcCtD
Clomipramine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000198	0.000564	CcSEcCtD
Clomipramine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000198	0.000564	CcSEcCtD
Clomipramine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000197	0.000563	CcSEcCtD
Clomipramine—Insomnia—Prednisone—ankylosing spondylitis	0.000197	0.000562	CcSEcCtD
Clomipramine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000195	0.000558	CcSEcCtD
Clomipramine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000195	0.000557	CcSEcCtD
Clomipramine—Cough—Methotrexate—ankylosing spondylitis	0.000195	0.000555	CcSEcCtD
Clomipramine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000194	0.000555	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—ankylosing spondylitis	0.000193	0.000551	CcSEcCtD
Clomipramine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000192	0.000547	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—ankylosing spondylitis	0.00019	0.000542	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—ankylosing spondylitis	0.00019	0.000542	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00019	0.000542	CcSEcCtD
Clomipramine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000189	0.00054	CcSEcCtD
Clomipramine—Rash—Prednisolone—ankylosing spondylitis	0.000189	0.000539	CcSEcCtD
Clomipramine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000189	0.000539	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000188	0.000538	CcSEcCtD
Clomipramine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000188	0.000537	CcSEcCtD
Clomipramine—Fatigue—Prednisone—ankylosing spondylitis	0.000188	0.000536	CcSEcCtD
Clomipramine—Headache—Prednisolone—ankylosing spondylitis	0.000188	0.000536	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—ankylosing spondylitis	0.000187	0.000535	CcSEcCtD
Clomipramine—Constipation—Prednisone—ankylosing spondylitis	0.000186	0.000532	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—ankylosing spondylitis	0.000183	0.000524	CcSEcCtD
Clomipramine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000182	0.00052	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000182	0.000519	CcSEcCtD
Clomipramine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000182	0.000519	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000179	0.000512	CcSEcCtD
Clomipramine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000179	0.000512	CcSEcCtD
Clomipramine—Asthenia—Betamethasone—ankylosing spondylitis	0.000179	0.000512	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000178	0.000509	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000178	0.000509	CcSEcCtD
Clomipramine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000178	0.000508	CcSEcCtD
Clomipramine—Nausea—Prednisolone—ankylosing spondylitis	0.000178	0.000508	CcSEcCtD
Clomipramine—Pruritus—Betamethasone—ankylosing spondylitis	0.000177	0.000505	CcSEcCtD
Clomipramine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000177	0.000505	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000177	0.000505	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000176	0.000502	CcSEcCtD
Clomipramine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000175	0.0005	CcSEcCtD
Clomipramine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000175	0.000499	CcSEcCtD
Clomipramine—Rash—Triamcinolone—ankylosing spondylitis	0.000174	0.000496	CcSEcCtD
Clomipramine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000174	0.000496	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—ankylosing spondylitis	0.000173	0.000495	CcSEcCtD
Clomipramine—Rash—Methylprednisolone—ankylosing spondylitis	0.000173	0.000495	CcSEcCtD
Clomipramine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000173	0.000494	CcSEcCtD
Clomipramine—Urticaria—Prednisone—ankylosing spondylitis	0.000173	0.000494	CcSEcCtD
Clomipramine—Headache—Triamcinolone—ankylosing spondylitis	0.000173	0.000493	CcSEcCtD
Clomipramine—Headache—Methylprednisolone—ankylosing spondylitis	0.000172	0.000492	CcSEcCtD
Clomipramine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000172	0.000491	CcSEcCtD
Clomipramine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000172	0.000491	CcSEcCtD
Clomipramine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000171	0.000488	CcSEcCtD
Clomipramine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000171	0.000488	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—ankylosing spondylitis	0.00017	0.000485	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000166	0.000473	CcSEcCtD
Clomipramine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000165	0.000472	CcSEcCtD
Clomipramine—Dizziness—Betamethasone—ankylosing spondylitis	0.000165	0.000472	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—ankylosing spondylitis	0.000165	0.00047	CcSEcCtD
Clomipramine—Nausea—Triamcinolone—ankylosing spondylitis	0.000164	0.000467	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000163	0.000466	CcSEcCtD
Clomipramine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000163	0.000466	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000162	0.000463	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—ankylosing spondylitis	0.000162	0.000462	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00016	0.000458	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00016	0.000457	CcSEcCtD
Clomipramine—Vomiting—Betamethasone—ankylosing spondylitis	0.000159	0.000454	CcSEcCtD
Clomipramine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000159	0.000454	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000158	0.000452	CcSEcCtD
Clomipramine—Rash—Betamethasone—ankylosing spondylitis	0.000158	0.00045	CcSEcCtD
Clomipramine—Rash—Dexamethasone—ankylosing spondylitis	0.000158	0.00045	CcSEcCtD
Clomipramine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000157	0.00045	CcSEcCtD
Clomipramine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000157	0.00045	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000157	0.000448	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—ankylosing spondylitis	0.000157	0.000448	CcSEcCtD
Clomipramine—Headache—Dexamethasone—ankylosing spondylitis	0.000157	0.000447	CcSEcCtD
Clomipramine—Headache—Betamethasone—ankylosing spondylitis	0.000157	0.000447	CcSEcCtD
Clomipramine—Asthenia—Prednisone—ankylosing spondylitis	0.000156	0.000446	CcSEcCtD
Clomipramine—Pain—Methotrexate—ankylosing spondylitis	0.000156	0.000444	CcSEcCtD
Clomipramine—Pruritus—Prednisone—ankylosing spondylitis	0.000154	0.00044	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00015	0.000428	CcSEcCtD
Clomipramine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000149	0.000425	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000149	0.000425	CcSEcCtD
Clomipramine—Nausea—Dexamethasone—ankylosing spondylitis	0.000148	0.000424	CcSEcCtD
Clomipramine—Nausea—Betamethasone—ankylosing spondylitis	0.000148	0.000424	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—ankylosing spondylitis	0.000145	0.000413	CcSEcCtD
Clomipramine—Dizziness—Prednisone—ankylosing spondylitis	0.000144	0.000411	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000144	0.000411	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000144	0.000411	CcSEcCtD
Clomipramine—Vomiting—Prednisone—ankylosing spondylitis	0.000138	0.000395	CcSEcCtD
Clomipramine—Rash—Prednisone—ankylosing spondylitis	0.000137	0.000392	CcSEcCtD
Clomipramine—Dermatitis—Prednisone—ankylosing spondylitis	0.000137	0.000392	CcSEcCtD
Clomipramine—Headache—Prednisone—ankylosing spondylitis	0.000136	0.000389	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000134	0.000383	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—ankylosing spondylitis	0.000131	0.000373	CcSEcCtD
Clomipramine—Nausea—Prednisone—ankylosing spondylitis	0.000129	0.000369	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—ankylosing spondylitis	0.000129	0.000368	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000124	0.000355	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—ankylosing spondylitis	0.00012	0.000344	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—ankylosing spondylitis	0.000116	0.00033	CcSEcCtD
Clomipramine—Rash—Methotrexate—ankylosing spondylitis	0.000115	0.000328	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000115	0.000327	CcSEcCtD
Clomipramine—Headache—Methotrexate—ankylosing spondylitis	0.000114	0.000325	CcSEcCtD
Clomipramine—Nausea—Methotrexate—ankylosing spondylitis	0.000108	0.000309	CcSEcCtD
